{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260501334677/en/Incyte-Announces-FDA-Approval-of-Jakafi-XR%E2%84%A2-ruxolitinib-Extended-Release-Tablets-for-the-Treatment-of-Myelofibrosis-Polycythemia-Vera-and-Graft-Versus-Host-Disease", "message": "News view counter 698853 successfully enlarged"}